Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Heartland Bank & Trust Co

Heartland Bank & Trust Co cut its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,244 shares of the medical equipment provider’s stock after selling 259 shares during the period. Heartland Bank & Trust Co’s holdings in Intuitive Surgical were worth $998,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at about $26,000. Creekmur Asset Management LLC raised its stake in Intuitive Surgical by 200.0% during the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 42 shares during the period. LGT Financial Advisors LLC boosted its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 54 shares during the last quarter. Delos Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the period. Finally, LRI Investments LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently commented on the company. Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a report on Monday, July 15th. BTIG Research upped their price target on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Barclays raised their price objective on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Piper Sandler upped their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Finally, Robert W. Baird increased their target price on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a research note on Friday, July 19th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Intuitive Surgical Trading Up 2.5 %

NASDAQ:ISRG opened at $491.27 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.18. The firm has a market cap of $174.25 billion, a PE ratio of 88.68, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. The stock has a fifty day moving average price of $473.63 and a 200 day moving average price of $429.56.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The company’s revenue was up 14.5% on a year-over-year basis. During the same period last year, the business earned $1.18 EPS. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.22 EPS for the current year.

Insider Buying and Selling

In related news, insider Mark Brosius sold 2,115 shares of the stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total value of $1,040,389.65. Following the transaction, the insider now directly owns 295 shares of the company’s stock, valued at approximately $145,113.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total value of $641,382.00. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Mark Brosius sold 2,115 shares of the business’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares in the company, valued at $145,113.45. The disclosure for this sale can be found here. Insiders sold a total of 53,120 shares of company stock worth $25,528,753 over the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.